Clinical Trial Update: Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled trial evaluating mesalamine for uncomplicated diverticular disease (colonic diverticulosis) has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colonic Diverticulosis

Drugs mentioned

• Mesalamine (Mesalamine)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Colonic Diverticulosis | Phase 2 | Status: COMPLETED